Skip to main content
. 2021 Jul 9;54(8):e13088. doi: 10.1111/cpr.13088

FIGURE 1.

FIGURE 1

BCAS3 expression is elevated in breast cancer tissues and predicts poor prognosis. (A). Analysis of BCAS3 alteration frequency in the multi‐cancer panel. (B). Analysis of BCAS3 alteration frequency in multiple BRCA cohorts. (C). Representative 2 BRCA cases with high BCAS3 expression in tumour tissue analysed by IHC staining. Scale Bars, 100 µm for ‘up’ and 25 µm for ‘down’. (D). Histoscores for BCAS3 in normal and tumour tissues. (E). BCAS3 mRNA expression is correlated with TNM stages in BRCA samples from LinkedOmics. (F). High BCAS3 expression is correlated with low overall survival in patients with breast carcinoma